Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Spreading of Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06785870
What this trial is testing

EVAluation of Erythrocytosis PRospEctive Cohort STudy

Who this might be right for
ErythrocytosisPolycythemiaPolycythemia Secondary+5 more
Cyrus Hsia 1,500
Large-scale testing (Phase 3)Study completedNCT00395070
What this trial is testing

Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 Melanoma

Who this might be right for
Metastatic Melanoma
Vical 390
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07521670
What this trial is testing

Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)

Who this might be right for
Recurrent Adenoid Cystic CarcinomaAdenoid Cystic Carcinoma MetastaticPapillary Thyroid Carcinoma
National Cancer Centre, Singapore 68
Large-scale testing (Phase 3)WithdrawnNCT03811418
What this trial is testing

Compare Pertuzumab + Trastuzumab + Vinorelbine vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast Cancer

Who this might be right for
Advanced Breast CancerHER2-positive Breast Cancer
iOMEDICO AG
Not applicableStudy completedNCT00096590
What this trial is testing

Detecting Abnormal Blood Clotting in Patients With Metastatic Cancer Undergoing Surgery

Who this might be right for
ThromboembolismUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Ended earlyNCT00496379
What this trial is testing

ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain Metastases

Who this might be right for
Breast CancerCNS Disease
Nancy Lin, MD 15
Not applicableUnknownNCT06172179
What this trial is testing

Construction and Validation of a Risk Prediction Model for Secondary Vertebral Fracture in Patients With Osteoporotic Vertebral Compression Fractures After Percutaneous Vertebroplasty

Who this might be right for
Osteoporotic Vertebral FracturePrediction Model
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 500
Not applicableUnknownNCT02103179
What this trial is testing

VEGF Signaling Promotes Cell Growth and Metastasis in Extrahepatic Cholangiocarcinoma in a VEGF Receptor Mediated Pathway (ECC)

Who this might be right for
Extrahepatic Cholangiocarcinoma
First Affiliated Hospital, Sun Yat-Sen University 20
Not applicableStudy completedNCT00410579
What this trial is testing

Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers

Who this might be right for
Colorectal CancerFatigueLong-term Effects Secondary to Cancer Therapy in Adults+2 more
NSABP Foundation Inc 744
Testing effectiveness (Phase 2)Study completedNCT02536742
What this trial is testing

Palbociclib in Molecularly Characterized ER-positive/HER2-negative Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
ETOP IBCSG Partners Foundation 124
Large-scale testing (Phase 3)Study completedNCT03306394
What this trial is testing

Trifluridine/Tipiracil (Also Known as S 95005 or TAS-102) in Patients With a Pretreated Colorectal Cancer That Has Spread (Metastatic).

Who this might be right for
Metastatic Colorectal Cancer
Institut de Recherches Internationales Servier 907
Not applicableStudy completedNCT00940355
What this trial is testing

Secondary Prevention of Problems in Health Status in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary DiseaseHealth Status
Radboud University Medical Center 303
Testing effectiveness (Phase 2)Looking for participantsNCT06832774
What this trial is testing

Exploration of Treatment Effect of Novel Hormone Therapy Combined With Local Treatment Based on PSMA PET/CT Evaluation in mHSCP Patients

Who this might be right for
Prostate Cancer Metastatic Disease
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 192
Not applicableStudy completedNCT03433560
What this trial is testing

An Observational Study to Evaluate the Safety and Efficacy of Pegfilgrastim (Neulasta®)

Who this might be right for
Breast Cancer FemaleBreast Neoplasm Female
Kyowa Kirin Korea Co., Ltd. 1,300
Not applicableUnknownNCT04351282
What this trial is testing

SBRT for Oligo-metastatic Lesions After Systemic Treatment of Primary Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaMetastasisStereotactic Body Radiation Therapy
Fudan University 43
Testing effectiveness (Phase 2)Looking for participantsNCT06130280
What this trial is testing

Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal Cancer

Who this might be right for
Colorectal CancerLiver Metastases
Memorial Sloan Kettering Cancer Center 32
Not applicableUnknownNCT03830242
What this trial is testing

Diagnostic Significance of FDG PET/CT Dynamic Imaging in Detecting Metastatic Lymph Nodes With Papillary Thyroid Cancer.

Who this might be right for
Positron-Emission TomographyLymph Node MetastasesThyroid Cancer
Fifth Affiliated Hospital, Sun Yat-Sen University 50
Early research (Phase 1)Study completedNCT05990920
What this trial is testing

Study of Allogeneic Blood-derived Natural Killer Cells to Evaluate Safety and Tolerability in Cancer Refractory to Conventional Therapy

Who this might be right for
Pathologically Confirmed Cancer Refractory to Conventional TherapyRefractory CancerMetastatic Cancer+5 more
NKGen Biotech, Inc. 6
Testing effectiveness (Phase 2)Looking for participantsNCT07410520
What this trial is testing

PD-1 Inhibitor Combined With Rituximab, Methotrexate, and Orelabrutinib (PD-1i+RMO) for Newly Diagnosed PCNSL and SCNSL.

Who this might be right for
Primary Central Nervous System Lymphoma (PCNSL)Secondary Central Nervous System Lymphoma (SCNSL)
The First Affiliated Hospital with Nanjing Medical University 50
Not applicableEnded earlyNCT00595296
What this trial is testing

GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study

Who this might be right for
Breast Cancer
Janssen Diagnostics, LLC 461
Next Page